Akili Interactive’s Video Game for ADHD Gets the FDA All Clear
Summary
Underpinning the engaging onscreen imagery is Akili’s core technology, called the Akili Selective Stimulus Management Engine. This spring Akili made its game available on a limited basis, based on new FDA guidance supporting the use of new digital technologies for treating psychiatric disorders in light of the COVID-19 outbreak. Speaking last month at Xconomy’s Xcelerating Life Sciences Boston event, Akili CEO Eddie Martucci said that the pandemic is creating a “new normal” in which patients and clinicians are looking for alternatives to pills. Akili did not specify a launch date for EndeavorRx, other than to say it would be “soon.” But the company says the game will be the centerpiece of a program that includes a mobile tracking app and support services for a child’s caregivers. The company adds that its game should be part of a broader approach to ADHD that may include therapy, medication, and educational programs.
Classifications
AskAI Classifications
LabelsLinked Companies
